COMPANY NEWS

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

March 28, 2018
TORONTO, March 28, 2018 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer

March 6, 2018
TORONTO, March 06, 2018 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a...
Read More

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

March 2, 2018
TORONTO, ON, March 1, 2018 3D Signatures Inc. (TSXV: DXD; OTCQB: TDSGF; FSE: 3D0) (the "Company" or "3DS"), a personalized...
Read More

3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HLᵀᴹ Test for Hodgkin’s Lymphoma

February 20, 2018
TORONTO, February 20, 2018 3D Signa­­­­­­tures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a...
Read More

3D Signatures Inc. Announces Changes To Its Board of Directors

February 13, 2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, February 12, 2018 - 3D Signatures...
Read More

3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement

December 6, 2017
TORONTO, December 5, 2017 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES 3D Signatures...
Read More

3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results

December 1, 2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE)...
Read More

3D SIGNATURES REPORTS FIRST QUARTER FINANCIAL RESULTS FOR FISCAL 2018

November 30, 2017
TORONTO, ON (November 29, 2017) 3D Signatures Inc. (TSXV: DXD; OTCQB: TDSGF; FSE:3D0) (the "Company" or "3DS"), a personalized medicine company...
Read More

3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement

November 30, 2017
TORONTO, November 27, 2017 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES 3D Signatures...
Read More

3D Signatures Inc. Announces Brokered Private Placement

October 25, 2017
TORONTO, ONTARIO--(Marketwired - Oct. 25, 2017) - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...
Read More